CLINICAL_TRIALS
trial_result
· 2025-01-17
Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months [Phase 3]
Summary
Phase 3 trial evaluating avatrombopag for immune thrombocytopenia in pediatric patients completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sobi, Inc. | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2025-01-17